Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary K Miller

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology|February 14, 2009
Measurements of birth defect prevalence: which is most useful as a comparator group for pharmaceutical pregnancy registries?Angela Scheuerle, Vani X Vannappagari, Mary K Miller
Organic Letters|March 23, 2019
Nickel(II)-Promoted Amide N-H Arylation of Pyroglutamate-Histidine with Arylboronic Acid ReagentsKengo Hanaya, Mary K Miller, Zachary T Ball
Organic Letters|July 2, 2021
Boronic Acid Pairs for Sequential BioconjugationMary K Miller, Michael J Swierczynski, Yuxuan Ding, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 22, 2010
Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery systemCarlos Iribarren, Irina V Tolstykh, Mary K Miller, et al.
Respiratory Medicine|August 18, 2006
Recent asthma exacerbations: a key predictor of future exacerbationsMary K Miller, June H Lee, Dave P Miller, et al.
Chest|May 5, 2009
Churg-strauss syndrome in patients treated with omalizumabMichael E Wechsler, Dennis A Wong, Mary K Miller, et al.
Angewandte Chemie (International Ed. in English)|January 23, 2018
A Three-Component Organometallic Tyrosine BioconjugationJun Ohata, Mary K Miller, Courtney M Mountain, et al.
American Journal of Epidemiology|November 10, 2012
Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohortsCarlos Iribarren, Irina V Tolstykh, Mary K Miller, et al.
Chemical Science|June 7, 2021
Copper-mediated peptide arylation selective for the N-terminusMary K Miller, Haopei Wang, Kengo Hanaya, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 17, 2012
Longitudinal changes in asthma control with omalizumab: 2-year interim data from the EXCELS StudyMark D Eisner, James L Zazzali, Mary K Miller, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Birth Defects Research. Part A, Clinical and Molecular Teratology|February 14, 2009
Measurements of birth defect prevalence: which is most useful as a comparator group for pharmaceutical pregnancy registries?Angela Scheuerle, Vani X Vannappagari, Mary K Miller
Organic Letters|March 23, 2019
Nickel(II)-Promoted Amide N-H Arylation of Pyroglutamate-Histidine with Arylboronic Acid ReagentsKengo Hanaya, Mary K Miller, Zachary T Ball
Organic Letters|July 2, 2021
Boronic Acid Pairs for Sequential BioconjugationMary K Miller, Michael J Swierczynski, Yuxuan Ding, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 22, 2010
Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery systemCarlos Iribarren, Irina V Tolstykh, Mary K Miller, et al.
Respiratory Medicine|August 18, 2006
Recent asthma exacerbations: a key predictor of future exacerbationsMary K Miller, June H Lee, Dave P Miller, et al.
Chest|May 5, 2009
Churg-strauss syndrome in patients treated with omalizumabMichael E Wechsler, Dennis A Wong, Mary K Miller, et al.
Angewandte Chemie (International Ed. in English)|January 23, 2018
A Three-Component Organometallic Tyrosine BioconjugationJun Ohata, Mary K Miller, Courtney M Mountain, et al.
American Journal of Epidemiology|November 10, 2012
Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohortsCarlos Iribarren, Irina V Tolstykh, Mary K Miller, et al.
Chemical Science|June 7, 2021
Copper-mediated peptide arylation selective for the N-terminusMary K Miller, Haopei Wang, Kengo Hanaya, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 17, 2012
Longitudinal changes in asthma control with omalizumab: 2-year interim data from the EXCELS StudyMark D Eisner, James L Zazzali, Mary K Miller, et al.
Pageof 3